Arkolith/Insider Trading/AERI/Form 4

Gryska David W

DirectorAERIE PHARMACEUTICALS INC (AERI) · full profile →Form 4 · filed Nov 21, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 21, 2022Disposed to issuer(D)11K$15.25$175K0
Nov 21, 2022Disposed to issuer(D)2K$15.25$30K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 21, 2022Disposed to issuer(D)17K$9.14$154K0
Nov 21, 2022Disposed to issuer(D)8K$1.98$15K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-058176) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML